Big pharma vs biotech and the future of marketing - European Medical Journal

Big pharma vs biotech and the future of marketing

EMJ GOLD
Season 02: Episode 21

In an interview double bill, Helena and Marc are joined by two fantastic guests from the worlds of pharma marketing and commercial affairs.

To kick off the episode, Marc chats to Michele Manto, Chief Commercial Officer, Galapagos, who shares his thoughts on moving from big pharma to biotech, how the pandemic has changed his outlook as well as his organisations, plus his advice on the art of knowing when to say ‘yes’ to new opportunities.

Then Robert Grimm, Digital Marketing and Transformation Manager, Novo Nordisk, takes up the mic to share his marketing knowledge and expertise, including his top tips for developing marketing campaigns and his predictions for the future of pharma marketing.

And in ‘News you might have missed’, we cover Sanofi’s fantastic decision to slash insulin prices for people with diabetes in the US without insurance, and lots more.

A little more on GOLD’s guests…

Michele Manto is passionate about bringing life-changing innovation from the lab to patients and society. As Chief Commercial Officer, he is responsible for building and leading Galapagos’ commercialisation organisation and capabilities, as Galapagos evolves into a fully integrated biopharmaceutical company. A management engineering graduate, Michele joined the pharmaceutical industry in 2004 and has worked in Italy, France, Switzerland, Germany, Netherlands and the US. He joined Galapagos in 2017, bringing with him extensive rheumatology and immunology experience – ideal for a company focused on inflammatory disease.

Robert Grimm is a digital marketing mogul, holding 10 years of experience within the field across five continents. Having worked in a range of industries, including healthcare and eCommerce marketing, he made his way into the pharmaceutical industry upon joining life sciences company TrialBee in 2019, where he worked to digitalise clinical research and patient recruitment. Now, as Digital Marketing and Transformation Manager at Novo Nordisk, Robert has assisted the company in fostering a customer-centric mindset.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.